Background: Atopic dermatitis (AD) is characterized by pruritic and eczematous skin lesions, which often cause depressive symptoms, anxiety, stress, sleep disturbances, social withdrawal, and stigmatization. Methods: In total, 23,442 subjects (434 AD patients and 23,008 control subjects) aged 19 years or older and without a history of major medical illness or depressive disorders were selected from The Fifth Korea National Health and Nutrition Examination Survey 2007-2012. Following the initial selection, 2,170 age-and sex-matched control subjects were selected using 1:5 propensity score matching. Multiple logistic regression analysis was performed to identify the presence of depressive symptoms of at least 2 weeks in duration. Results: The demographic, socioeconomic, and clinical characteristics of AD patients and control subjects were presented and compared, and some variables differed significantly between groups. Presence of depressive symptoms was set as dependent variable, and multiple logistic regression analysis was performed as follows: (1) unadjusted; (2) with alcohol use, exercise status, smoking status, and body mass index (BMI) adjusted for; and (3) with alcohol use, exercise status, smoking status, marital status, occupation, BMI, total caloric intake, history of hypertension, and history of diabetes mellitus adjusted for. Depressive symptoms were significantly higher (odds ratios, 1.46, 1.40, and 1.36; 95% confidence intervals, 1.09-1.95, 1.0.4-1.88, and 1.01-1.85, respectively) in AD patients relative to those of matched controls. Conclusion: AD and clinical depression interact closely, and causal relationships between the two conditions have frequently been observed. Physicians should consider mental health interventions cautiously. It is particularly important that primary care physicians provide comprehensive, continuous long-term care.
INTRODUCTION
Atopic dermatitis (AD) is currently one of the most prevalent chronic relapsing skin diseases diagnosed and treated by primary care physicians nationally in South Korea and also globally. It is characterized by pruritic and eczematous skin lesions, 1) which often cause depressive symptoms, anxiety, stress, and sleep and psychological disturbances such as social withdrawal and stigmatization. The age of onset is between 1 year in approximately 50% of patients and 5 years in approximately 90% of patients, and in most cases, the skin lesions resolve before the patient reaches the age of 12 years.
2) The lesions persist throughout adolescence and early adulthood in less than 10% of patients, who demonstrate lower levels of treatment compliance and adherence, poorer quality of life, and greater psychosocial disturbance, relative to that of younger patients.
Recently, the need to strengthen patient education and adopt a multifaceted approach to the management of chronic relapsing skin diseases has been emphasized in international studies, because the area of science known as psychodermatology is evolving.
3) According to the categorization outlined in psychodermatology, AD is a psychophysiological disorder, and while stress does not cause AD, it could be precipitate or exacerbate the condition, and emotional factors determine the natural course of the disease. 3) Few studies have been conducted to examine the association between AD and clinically significant depressive symptoms in Korean adults in multicenter settings on a national scale. Therefore, we sought to clarify the similarities and differences, with respect to demographic, socioeconomic, and clinical characteristics, between AD patients and control subjects in the Fifth Korea National Health and Nutrition Examination Survey 2007-2012 (KNHANES) and conducted multiple logistic regression analysis to determine whether there was a statistically significant difference in clinically significant depressive symptoms of at least 2 weeks in duration between the two groups. In addition, we sought to discuss means via which primary care physicians could improve AD management. This cross-sectional study was the first to examine the association between AD and mental health using KNHANES data for sufficient numbers of adult patients and control subjects.
METHODS

Subjects
Initially, 23,442 subjects were selected from the KNHANES according to the following selection criteria: age of 19 years or older and no history of cancer, stroke, cardiovascular disease, tuberculosis, chronic obstructive pulmonary disease, bronchiectasis, chronic kidney disease, thyroid disease, liver disease, or depressive disorders. Of the initial 23,442 subjects, 434 individuals with a current or previous diagnosis of AD and 2,170 age-and sex-matched control subjects were selected to participate in the study.
Study Variables
Subjects' demographic characteristics included age, sex, alcohol use, exercise status, and smoking status. Alcohol use was classified as follows: none, up to once per week, and at least twice per week. Exercise status was defined as follows: (1) Clinical characteristics included body mass index (BMI, kg/ m 2 ), waist circumference (cm), total caloric intake (kcal), history of hypertension diagnosed and managed by a physician, and history of diabetes mellitus (DM) diagnosed and managed by a physician. Depressive symptoms were considered present if they had lasted for at least 2 weeks. Data are presented as means ± standard errors or number (%).
Statistical Analysis
Descriptive analyses were conducted twice. The initial analysis included 23,008 control subjects and 434 AD patients. Thereafter, 2,170 age-and sex-matched control subjects were selected via 1:5 propensity score matching and reanalyzed. Study variables that were statistically significant in the descriptive analyses were included as independent variables, with the presence of depressive symptoms of at least 2 weeks in duration as the dependent variable. Multiple logistic regression analyses were performed as follows: (1) unadjusted; (2) with alcohol use, exercise status, smoking status, and BMI adjusted for; and (3) with alcohol use, exercise status, smoking status, marital status, occupation, BMI, total caloric intake, history of hypertension, and history of DM adjusted for. All analyses were performed using SAS ver. 9.3 (SAS Institute Inc., Cary, NC, USA). Results with a P-value of < 0.05 were considered statistically significant. Values are presented as mean ± standard error or number (%).
RESULTS
ses, 2,170 age-and sex-matched control subjects were included in a repeat analysis, the results of which are presented in the right column of Table 1 . Alcohol use, exercise status, and smoking status differed significantly between AD patients and unmatched control subjects, but these differences did not persist in the analysis involving matched control subjects. The proportions of AD patients who were nondrinkers (20.2%, 88 subjects) and nonsmokers (58.8%, 255 subjects) were slightly lower relative to those of matched control subjects (20.7%, 448 subjects and 62.4%, 1,354 subjects, respectively). In contrast, the proportion of AD patients who had engaged in exercise was slightly higher relative to that of matched control subjects (8.2%, 178 subjects).
Of the variables representing socioeconomic status (residential area, educational level, monthly household income, marital status, and occupation), only marital status differed significantly between AD patients and matched control subjects; consequently, there was no significant difference in overall socioeconomic status between these groups. The proportion of married AD patients (63.6%, 276 subjects) was significantly lower relative to that of matched control subjects (69.1%, 1,499 subjects).
With respect to depressive symptoms of at least 2 weeks in duration and clinical characteristics (BMI [kg/m 2 ], waist circumference [cm], total caloric intake [kcal], history of hypertension, and history of DM), depressive symptoms and history of hypertension differed significantly between AD patients and matched control subjects. The proportions of AD patients with depressive symptoms (16.1%, 70 subjects) and a history of hypertension (14.8%, 64 subjects) were significantly higher relative to those of matched control subjects (11.8%, 225 subjects and 10.3%, 223 subjects, respectively). Table 2 shows the results of the multiple logistic regression analysis that included variables for which results of the descriptive analyses were significant, as independent variables, and presence of depressive symptoms of at least 2 weeks in duration as the dependent variable. Multiple logistic regression analyses were performed as follows: (1) unadjusted; (2) with alcohol use, exercise status, smoking status, and BMI adjusted for; and (3) with alcohol use, exercise status, smoking status, marital status, occupation, BMI, total caloric intake, history of hypertension, and history of DM adjusted for. In model 1, in which no adjustments were applied, the prevalence of depressive symptoms was significantly higher in AD patients (odds ratio, 1.46; 95% confidence interval, 1.09-1.95), relative to that of matched control subjects. This difference persisted in model 2 (odds ratio, 1.40; 95% confidence interval, 1.04-1.88). In model 3, all of the independent variables (alcohol use, exercise status, smoking status, marital status, occupation, BMI, total caloric intake, history of hypertension, and history of DM) were adjusted for, and the results of multiple logistic regression analysis showed an odds ratio of 1.36 (95% confidence interval, 1.01-1.85), indicating that the proportion of AD patients with depressive symptoms was 1.36 times higher relative to that of matched control subjects.
DISCUSSION
In total, 23,442 subjects aged 19 years or older without a history of major medical illnesses (i.e., cancer, stroke, cardiovascular disease, tuberculosis, chronic obstructive pulmonary disease, bronchiectasis, chronic kidney disease, thyroid disease, and liver disease) or depressive disorders were selected from the KNHANES, and multiple logistic regression analyses were performed to establish the presence of depressive symptoms of at least 2 weeks in duration. Three models, adjusted for statistically significant differences in demographic, socioeconomic, and clinical characteristics (marital status and history of hypertension) were produced for 434 AD patients and 2,170 age-and sex-matched control subjects. In all three models, levels of depressive symptoms in AD patients were significantly higher (odds ratios, 1.46, 1.40, and 1.36; 95% confidence intervals, 1.09-1.95, 1.04-1.88, and 1.01-1.85, respectively) relative to those of matched control subjects.
Results of extensive research have shown that chronic skin diseases, such as AD, which characteristically involve intense pruritus, cause psychosocial burden. Mental health disorders, including ADHD (attention deficit/hyperactivity disorder), depression, and autism, are known to be associated with AD. 4) In addition, psychological disturbances, such as depression, anxiety, and suicidal ideation, and high levels of stigmatization and social withdrawal are associated with the disease. 3, 5, 6) The incidence of three mental health comorbidities, depression, anxiety, and suicidal ideation, had increased significantly in a 2015 study involving 4,994 individuals from 13 European countries. 5) From this perspective, psychodermatology has recently published a number of studies that were conducted to improve both dermatological conditions and patients' quality of life. The monitoring of stress levels, depressive symptoms, suicidal ideation, and quality of sleep, which are important indices of mental health comorbidities and quality of life, should be taken into consideration and incorporated into management. AD and clinical depression interact closely, and causal relationships between the two conditions have frequently been observed; for example, the onset or exacerbation of AD often follows stressful life events such as severe disease in a family member, divorce, or parental separation. 7) In addition, AD patients, particularly those suffering from pruritus, experience psychological disturbances such as anxiety and depression. The following mechanisms could underlie this relationship: modulation of pruritus perception, 8) perturbation of epidermal permeability barrier homeostasis, 9) and acceleration of immune responses.
10) The acceleration of interactions between the two conditions occurs within a vicious cycle; therefore, all physicians, including both psychiatrists and nonpsychiatrists, should always consider mental health interventions (psychological, behavioral, and psychoeducational therapies and medications including antidepressants and anxiolytics) cautiously. Traditionally, other than conventional lifestyle modifications, little assistance is provided for AD patients in most clinics in Korea, but those interventions are considered important in controlling the dermatological condition in longstanding cases. It is particularly important that primary care physicians provide comprehensive, continuous long-term care.
Few studies have been conducted to examine mental health and quality of life in chronic dermatology patients in Korea; therefore, there is a definite need for further research to investigate the association between AD and mental health in sufficient numbers of adult patients and control subjects, using national data from the KNHANES. We selected depressive symptoms of at least 2 weeks in duration to represent general mental health, as this is one of diagnostic criteria for major depressive disorders in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders and one of the most common symptoms of stressful and depressive mental conditions. The proportion of AD patients with depressive symptoms was 1.36 times higher relative to that of control subjects. Many previous studies have involved pediatric patients; therefore, questions concerning mental health and quality of life were often answered by parents or other caregivers rather than the patients. In contrast, our study included a sufficient number of adult patients, who had suffered from chronic relapsing conditions and were able to assess their own mental health and quality of life accurately.
The only mental health variable used in the study was depressive symptoms of at least 2 weeks in duration, which did not appear to be strong enough for the diagnosis or indication of major depressive or anxiety disorders. It is also limited as the sole indicator for need for psychiatric or psychosocial interventions. Therefore, we future studies should include refined assessment tools, such as questions reflecting diagnostic criteria, the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, or severity assessments such as those of the SCORing Atopic Dermatitis Index. 2, 11) In addition, attempts have recently been made to develop new psychosomatic scales (e.g., the Psychosomatic Diagnostic Criteria for Atopic Dermatitis and Psychosomatic Scale for Atopic Dermatitis, 3, 12, 13) which should be used in future studies. Studies examining the efficacy of various mental health interventions, such as those mentioned above, should be conducted in clinical settings and include Korean adults.
